These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Pseudo-Anaphylactic Reactions to Pfizer BNT162b2 Vaccine: Report of 3 Cases of Anaphylaxis Post Pfizer BNT162b2 Vaccination. Lim XR; Leung BP; Ng CYL; Tan JWL; Chan GYL; Loh CM; Tan GLX; Goh VHH; Wong LT; Chua CR; Tan SC; Lee SSM; Howe HS; Thong BYH; Leong KP Vaccines (Basel); 2021 Aug; 9(9):. PubMed ID: 34579211 [TBL] [Abstract][Full Text] [Related]
6. Assessment of Immediate Allergic Reactions After Immunization With the Pfizer BNT162b2 Vaccine Using Intradermal Skin Testing With the COVID-19 Vaccines. Shavit R; Maoz-Segal R; Offengenden I; Yahia SH; Maayan DM; Lifshitz Y; Niznik S; Deutch M; Elbaz E; Genaim H; Iancovici-Kidon M; Agmon-Levin N J Allergy Clin Immunol Pract; 2022 Oct; 10(10):2677-2684. PubMed ID: 35973526 [TBL] [Abstract][Full Text] [Related]
7. The role of lymphocyte transformation tests (LTT) in suspected severe delayed hypersensitivity reactions following COVID-19 vaccination. Weir C; Sung-In Jang H; Fernando SL Hum Vaccin Immunother; 2023 Dec; 19(1):2182527. PubMed ID: 36912718 [TBL] [Abstract][Full Text] [Related]
8. First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing. Wolfson AR; Robinson LB; Li L; McMahon AE; Cogan AS; Fu X; Wickner P; Samarakoon U; Saff RR; Blumenthal KG; Banerji A J Allergy Clin Immunol Pract; 2021 Sep; 9(9):3308-3320.e3. PubMed ID: 34166844 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of Allergic Reactions After Pfizer-BioNTech COVID-19 Vaccination Among Adults With High Allergy Risk. Shavit R; Maoz-Segal R; Iancovici-Kidon M; Offengenden I; Haj Yahia S; Machnes Maayan D; Lifshitz-Tunitsky Y; Niznik S; Frizinsky S; Deutch M; Elbaz E; Genaim H; Rahav G; Levy I; Belkin A; Regev-Yochay G; Afek A; Agmon-Levin N JAMA Netw Open; 2021 Aug; 4(8):e2122255. PubMed ID: 34463744 [TBL] [Abstract][Full Text] [Related]
10. COVID vaccination can be performed in patients with a history of allergic reactions to the vaccines or their components: experience from a specialist clinic in South Australia. Tunbridge M; Perkins G; Lee M; Salehi T; Ryoo D; Kette F; Smith W; Gold M; Le TA; Yuson C; Hissaria P Intern Med J; 2022 Nov; 52(11):1884-1890. PubMed ID: 35848521 [TBL] [Abstract][Full Text] [Related]
11. Vaccination counseling with and without excipient skin testing in patients with suspected allergic reactions to mRNA COVID-19 vaccines and patients with atopy. Khokhar D; O'Shea KM; Akin C; Baldwin JL; Benjamin MR; Ravikumar R; Hosler M; McMorris MS; Sanders GM; Troost JP; Baptist AP; Oberdoerster DT; Kovalszki A J Allergy Clin Immunol Glob; 2022 Nov; 1(4):209-216. PubMed ID: 36090592 [TBL] [Abstract][Full Text] [Related]
12. Basophil reactivity to BNT162b2 is mediated by PEGylated lipid nanoparticles in patients with PEG allergy. Troelnikov A; Perkins G; Yuson C; Ahamdie A; Balouch S; Hurtado PR; Hissaria P J Allergy Clin Immunol; 2021 Jul; 148(1):91-95. PubMed ID: 33991580 [TBL] [Abstract][Full Text] [Related]
13. The Polysorbate containing AstraZeneca COVID-19 vaccine is tolerated by polyethylene glycol (PEG) allergic patients. Sellaturay P; Gurugama P; Harper V; Dymond T; Ewan P; Nasser S Clin Exp Allergy; 2022 Jan; 52(1):12-17. PubMed ID: 34822190 [TBL] [Abstract][Full Text] [Related]
14. Pfizer/BioNtech BNT162b2: adverse events and insights from an Australian mass vaccination clinic for COVID-19. Halder A; Imamura H; Condon S; Boroughs K; Nilsson SC; Anderson T; Caterson ID Intern Med J; 2022 Jan; 52(1):121-124. PubMed ID: 35060290 [TBL] [Abstract][Full Text] [Related]
15. Assessment of Allergic and Anaphylactic Reactions to mRNA COVID-19 Vaccines With Confirmatory Testing in a US Regional Health System. Warren CM; Snow TT; Lee AS; Shah MM; Heider A; Blomkalns A; Betts B; Buzzanco AS; Gonzalez J; Chinthrajah RS; Do E; Chang I; Dunham D; Lee G; O'Hara R; Park H; Shamji MH; Schilling L; Sindher SB; Sisodiya D; Smith E; Tsai M; Galli SJ; Akdis C; Nadeau KC JAMA Netw Open; 2021 Sep; 4(9):e2125524. PubMed ID: 34533570 [TBL] [Abstract][Full Text] [Related]
16. Elucidating allergic reaction mechanisms in response to SARS-CoV-2 mRNA vaccination in adults. Shah MM; Layhadi JA; Hourcade DE; Fulton WT; Tan TJ; Dunham D; Chang I; Vel MS; Fernandes A; Lee AS; Liu J; Arunachalam PS; Galli SJ; Boyd SD; Pulendran B; Davis MM; O'Hara R; Park H; Mitchell LM; Akk A; Patterson A; Jerath MR; Monroy JM; Ren Z; Kendall PL; Durham SR; Fedina A; Gibbs BF; Agache I; Chinthrajah S; Sindher SB; Heider A; Akdis CA; Shamji MH; Pham CTN; Nadeau KC Allergy; 2024 Sep; 79(9):2502-2523. PubMed ID: 39033312 [TBL] [Abstract][Full Text] [Related]
17. Patients with previous immediate hypersensitivity reactions to polyethylene glycol can safely receive the BNT162b2 mRNA COVID-19 vaccine. Hurst M; Jordan A; Capstick J; Brewerton M; Cockroft R; Ingram J Intern Med J; 2022 Oct; 52(10):1818-1820. PubMed ID: 36000384 [TBL] [Abstract][Full Text] [Related]
18. Administration of the Second Dose of mRNA COVID-19 Vaccine to a Woman With Immediate Reaction to the First Dose. Apostolidou E; Dimitriou K; Papadopoulou A; Mikos N; Kompoti E Cureus; 2023 Mar; 15(3):e36064. PubMed ID: 37056532 [TBL] [Abstract][Full Text] [Related]
19. Coronavirus disease 2019 vaccine administration in patients with reported reactions to polyethylene glycol- and polysorbate-containing therapeutics. Otani IM; Tsao LR; Tang M Ann Allergy Asthma Immunol; 2022 Jul; 129(1):88-94.e1. PubMed ID: 35288274 [TBL] [Abstract][Full Text] [Related]
20. AstraZeneca ChAdOx1-S COVID-19 vaccine can be safely administered in patients with EDTA allergy. Ali SB; Perkins G; Ryoo D; Lee M; Tunbridge M; Yuson C; Smith W; Hissaria P; Le TT Allergy Asthma Clin Immunol; 2022 Mar; 18(1):22. PubMed ID: 35272714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]